Total Payments
$2,450
2022 Payments
$160.62
Companies
26
Transactions
116
Medicare Patients
3,172
Medicare Billing
$352,726
Payment Breakdown by Category
Food & Beverage$1,719 (70.2%)
Travel$730.70 (29.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,719 | 114 | 70.2% |
| Travel and Lodging | $730.70 | 2 | 29.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $887.95 | 5 | $0 (2022) |
| Novo Nordisk Inc | $389.51 | 30 | $0 (2022) |
| Lilly USA, LLC | $223.57 | 15 | $0 (2022) |
| ABBVIE INC. | $123.89 | 6 | $0 (2022) |
| Amgen Inc. | $110.28 | 8 | $0 (2022) |
| GlaxoSmithKline, LLC. | $106.26 | 8 | $0 (2022) |
| Purdue Pharma L.P. | $100.91 | 7 | $0 (2018) |
| Shire North American Group Inc | $69.89 | 6 | $0 (2019) |
| Astellas Pharma US Inc | $69.46 | 6 | $0 (2019) |
| Emmaus Medical, Inc. | $37.70 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $160.62 | 11 | Lilly USA, LLC ($47.57) |
| 2021 | $1,155 | 19 | Pacira Pharmaceuticals Incorporated ($876.08) |
| 2020 | $47.49 | 3 | Integra LifeSciences Corporation ($24.06) |
| 2019 | $289.47 | 23 | Novo Nordisk Inc ($144.44) |
| 2018 | $493.75 | 36 | Novo Nordisk Inc ($169.84) |
| 2017 | $303.50 | 24 | Purdue Pharma L.P. ($89.61) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 04/06/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Bone Health | ||||||
| 03/31/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Diabetes | ||||||
| 02/24/2022 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Neurology | ||||||
| 02/14/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Diabetes | ||||||
| 02/09/2022 | Pacira Pharmaceuticals Incorporated | Iovera (Device), Zilretta | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Pain Management | ||||||
| 01/26/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: VACCINES | ||||||
| 01/20/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 01/05/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Bone Health | ||||||
| 12/02/2021 | Emmaus Medical, Inc. | Endari (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Sickle Cell | ||||||
| 12/01/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Chronic Pain | ||||||
| 11/23/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 10/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 09/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 09/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2021 | Emmaus Medical, Inc. | Endari (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Sickle Cell | ||||||
| 08/18/2021 | Stryker Corporation | VARIAX (Device) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 08/17/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.37 | General |
| 08/02/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Bone Health | ||||||
| 07/10/2021 | Pacira Pharmaceuticals Incorporated | Iovera System (Device) | Food and Beverage | In-kind items and services | $46.03 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 995 | 1,640 | $420,424 | $118,148 |
| 2022 | 13 | 669 | 1,319 | $282,678 | $86,809 |
| 2021 | 9 | 652 | 921 | $226,731 | $75,111 |
| 2020 | 17 | 856 | 2,178 | $264,726 | $72,658 |
Total Patients
3,172
Total Services
6,058
Medicare Billing
$352,726
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64640 | Destruction of peripheral nerve or branch | Office | 2023 | 70 | 380 | $122,360 | $35,954 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 267 | 267 | $105,198 | $29,969 | 28.5% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 66 | 74 | $26,640 | $20,195 | 75.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 182 | $47,635 | $15,119 | 31.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 53 | 60 | $15,190 | $4,168 | 27.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 80 | 92 | $43,056 | $3,982 | 9.2% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 91 | 96 | $22,385 | $3,085 | 13.8% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 64 | 65 | $14,000 | $1,476 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 15 | $2,670 | $896.99 | 33.6% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 31 | 31 | $5,890 | $872.02 | 14.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 22 | 23 | $4,000 | $635.80 | 15.9% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 18 | 23 | $3,720 | $612.36 | 16.5% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 11 | 15 | $3,150 | $495.75 | 15.7% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 11 | 17 | $3,330 | $434.84 | 13.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 58 | 300 | $1,200 | $251.88 | 21.0% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2022 | 46 | 267 | $85,974 | $25,651 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 181 | 181 | $71,314 | $20,574 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 180 | $46,980 | $14,989 | 31.9% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2022 | 42 | 50 | $18,000 | $13,514 | 75.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 48 | 64 | $14,973 | $4,777 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 25 | $4,450 | $1,720 | 38.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 30 | 39 | $18,252 | $1,684 | 9.2% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 33 | 33 | $7,215 | $1,193 | 16.5% |
| 73502 | X-ray of hip, 2-3 views | Office | 2022 | 23 | 24 | $4,680 | $790.50 | 16.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 20 | 20 | $3,600 | $571.31 | 15.9% |
About Dr. Peter Loo, MD
Dr. Peter Loo, MD is a Sports Medicine healthcare provider based in Topeka, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2011. The National Provider Identifier (NPI) number assigned to this provider is 1275828535.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Loo, MD has received a total of $2,450 in payments from pharmaceutical and medical device companies, with $160.62 received in 2022. These payments were reported across 116 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,719).
As a Medicare-enrolled provider, Loo has provided services to 3,172 Medicare beneficiaries, totaling 6,058 services with total Medicare billing of $352,726. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Location Topeka, KS
- Active Since 06/15/2011
- Last Updated 12/08/2020
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1275828535
Products in Payments
- Iovera System (Device) $876.08
- TRULICITY (Drug) $190.36
- Ozempic (Drug) $144.89
- Victoza (Drug) $118.64
- VRAYLAR (Drug) $96.69
- VESICARE (Drug) $58.29
- ADVAIR (Drug) $52.44
- Tresiba (Drug) $46.94
- Prolia (Biological) $46.64
- Endari (Drug) $37.70
- EVENITY (Biological) $37.53
- VYVANSE (Drug) $36.17
- Vascepa (Drug) $30.20
- BUTRANS (Drug) $30.13
- Durolane (Device) $28.23
- HYSINGLA ER (Drug) $27.34
- UBRELVY (Drug) $27.20
- UTIBRON (Drug) $26.57
- Repatha (Biological) $26.11
- FARXIGA (Drug) $25.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Topeka
Timothy Gateley, D.p.m, D.P.M
Sports Medicine — Payments: $1,642
Sports Medicine $1,642
Dr. Ryan Tomlins, M.d, M.D
Sports Medicine — Payments: $1,505
Sports Medicine $1,505
Dr. Michael Mccoy, Md, MD
Sports Medicine — Payments: $95.93
Sports Medicine $95.93
Dr. Kellie Bartlow, Do, DO
Sports Medicine — Payments: $43.43
Sports Medicine $43.43
Dr. Morgan Birrell, Md, MD
Sports Medicine
Sports Medicine